1. Introduction
===============

The human gamma-herpesviruses, Epstein--Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV), are large DNA viruses that establish chronic latent infections and have undergone prolonged coevolution with their human hosts ([@vey040-B17]). Like all herpesviruses, the EBV and the KSHV life cycles have both lytic and latent stages. During latency, the viral genome replicates together with the host cell, protein expression is limited, and no virions are produced. The switch from latency to the lytic stage is essential for virus spreading and depends on the expression of key transcriptional activators and epigenetic modifications ([@vey040-B59]; [@vey040-B69]).

EBV is transmitted via saliva and infects ∼95% of the human population by adulthood ([@vey040-B29]). EBV infects epithelial and B cells, establishing latency primarily in B cells ([@vey040-B29]). Although EBV infections are often asymptomatic, it has been implicated in several malignancies including Burkitt's lymphoma (particularly in Africa; [@vey040-B62]), nasopharyngeal carcinoma (particularly in Asian adults; [@vey040-B40]), Hodgkin's lymphoma, gastric carcinoma, and breast cancer, among others (reviewed in [@vey040-B35]; [@vey040-B96]). KSHV is transmitted via salivary or sexual routes ([@vey040-B29]). This oncogenic virus has been associated with the development of Kaposi sarcoma, multicentric Castleman's disease and primary effusion lymphoma in immunocompromised patients. Transplant recipients are most susceptible to developing malignancies and non-neoplastic manifestation by KSHV primary infection or reactivation (reviewed in [@vey040-B73]). In contrast to EBV, KSHV can infect several cell types including B cells, epithelial cells, endothelial cells, monocytes and keratinocytes, and can establish latency in B cells and endothelial cells ([@vey040-B29]).

Following infection, many innate immune mechanisms are induced including complement activation, apoptotic response and cytokine production. Both EBV and KSHV have evolved counteraction mechanisms. For example, both viruses express gene products that mimic cellular cytokines. In this study, we focus on one particular innate immunity mechanism---the Activation-induced deaminase (AID)/APOBEC family of DNA editing enzymes---because evaluating the effects on viral genome evolution is tractable.

AID/APOBEC enzymes have roles in both innate and adaptive immunity. Functionally, the enzymes deaminate deoxycytosine to deoxyuracil on ssDNA substrates (and in some cases RNA) which may be exposed during transcription or replication; the U:G mismatch then becomes a C to T transition mutation if replicated over in the absence of DNA repair ([@vey040-B56]). The ancestral enzyme in the family, AID, is expressed in germinal center B cells and is required for the processes of somatic hypermutation and class-switch recombination that are part of antibody affinity maturation ([@vey040-B58]; [@vey040-B66]). AID deamination occurs preferentially at mutational 'hotspots' defined by the motif WR[C]{.ul} (W = A/T, R = A/G) ([@vey040-B67]). The APOBEC3 (A3) subfamily enzymes act as part of innate immunity against exogenous viruses and endogenous retroelements ([@vey040-B33]; [@vey040-B93]). Primates have seven A3 genes (A--D, F--H), each of which has evolved specific subcellular localization and expression patterns ([@vey040-B16]). Furthermore, different A3 genes have evolved different mutational hotspots ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). For example, A3G preferentially mutates at CC[C]{.ul} hotspots ([@vey040-B97]; Kohli et al. [@vey040-B42]), whereas for A3B it is T[C]{.ul} ([@vey040-B7]). However, a conclusive deamination preference has only been shown for AID and A3G. A recent study to determine the definitive hotspot motif for A3A and A3B was recently done using deep-sequencing, but this study failed to consider the possible biased effects of DNA repair enzymes ([@vey040-B82]). Another study showed a preferential motif of YYCR (Y =C/T, R = A/G) for A3A, but specific binding motifs depended on the pH level during the binding event ([@vey040-B67]). Furthermore, crystal structures of the A3 enzymes have been studied for hotspot preferences, but nucleotide positions 5′ and 3′ of the potential mutated cytosine were not definitively characterized ([@vey040-B77]).

A role for A3 enzymes in viral restriction has been described for several retroviruses and DNA viruses (reviewed in [@vey040-B53]; [@vey040-B33]; [@vey040-B93]). In the well-studied case of HIV, A3G targets nascent DNA during reverse transcription. However, HIV encodes the counteracting protein Vif, which targets the A3 enzymes for proteasomal degradation. Interestingly, several recent studies have suggested the possibility of a proviral role for A3G in which the enzyme also helps to generate escape variants ([@vey040-B94]; [@vey040-B54], [@vey040-B55]). DNA viruses targeted by A3 enzymes include human papillomavirus, hepatitis B and C virus (HBV and HCV), herpes simplex virus-1 (HSV-1) and EBV (reviewed in [@vey040-B53]; [@vey040-B33]; [@vey040-B93]). Overexpression of A3C has been reported to target the plus and minus DNA strands of HSV-1 and EBV lytic and latent genes, respectively ([@vey040-B87]). Also, prolonged exposure to AID inhibits KSHV viral lytic reactivation and limits virion infectivity ([@vey040-B4]).

Several recent studies have shown that mis-regulation and mis-targeting of AID/APOBEC enzymes can contribute to the development of malignancies. In particular, mutation signatures associated with AID/APOBEC hotspots have been identified in Burkitt's lymphoma, breast and gastric cancer, among others (reviewed in [@vey040-B70]). In EBV-infected cells, the EBV LMP-1 and EBNA-3C latent proteins upregulate AID expression by mimicking the active form of CD40 ([@vey040-B27]), and by direct regulation of the AID (AICDA) gene, respectively ([@vey040-B41]). KSHV infected B cells also show increased AID expression ([@vey040-B4]). Gene expression data from the GTEx Consortium show an increase not only in the mRNA levels of AID but also in almost all of the A3 enzymes (except for A3A) in EBV-transformed lymphocytes when compared with the mRNA levels observed in spleen cells (see [Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}).

Given the existing evidence associating certain mutations in the virus with tumor development, it is important to identify the mechanisms driving genetic diversity and evolution in human gamma-herpesviruses ([@vey040-B70]). Previous work by ourselves used computational methods to address the question of why these enzymes evolved their particular mutational hotspots ([@vey040-B14]). Here, we consider in more detail the impact of the AID/A3 family on the evolution of the human gamma-herpesviruses. Human gamma-herpesviruses have undergone a prolonged coexistence with humans and would be expected to have evolved as much as possible to limit the detrimental effects of AID/APOBECs, or potentially use them for their benefit by generating adaptive variation. Assuming that a prolonged coevolution has already shaped the evolution of the viruses, then experiments involving AID/A3 gene knockouts will most likely be uninformative because AID/A3 effects are expected to be small. We consider that analyzing viral genomes for the evidence of previous evolution in the presence of AID/A3 will be more informative. In this study, we used computational methods to investigate the extent to which the EBV and KSHV genomes (1) have evolved to limit the number of hotspot motifs to avoid AID/A3 mutations, and (2) to determine the hypermutation due to AID/A3 in these viruses.

2. Materials and Methods
========================

2.1 Dataset
-----------

For this analysis, we used complete or near complete viral genome sequences without ambiguous nucleotides. The DNA sequence of the EBV and KSHV viral genomes analyzed were obtained from NCBI-Nucleotide Database. [Supplementary Table S2](#sup1){ref-type="supplementary-material"} lists the accession number, strain name, and country of isolation.

2.2 Quantification of hotspot representation
--------------------------------------------

The quantification of AID and A3 hotspot representation in the gamma-herpesviruses was determined using the cytidine deaminase representation reporter (CDUR) ([@vey040-B81]). This reporter consists of different shuffling algorithms that generate a null distribution of 1,000 random sequences from a subject sequence, and compares the number of hotspots in the sequence of interest to this null model. The null model is generated differently for coding versus noncoding regions. For noncoding sequences, we used the random module in Biopython to generate 1,000 shuffled sequences that strictly conserved the GC content of the DNA sequence as variations in GC content itself can lead to different representations of A3 hotspots ([@vey040-B14]). For coding sequences, we used the n3 sequence shuffling; this method shuffles the third position nucleotide in the codon while maintaining the encoded protein sequence. Because this method shuffles the nucleotides in the sequence of interest, it maintains the overall GC content of the coding sequences. However, it changes the codon usage bias. The *P*-value for hotspot under-representation was calculated as the proportion of null model sequences with fewer than *n* hotspots, where *n* was the number of hotspots in the actual sequence. Over-representation was measured as 1 minus the reported *P*-value for under-representation. The set of *P*-values computed for the coding sequences were adjusted for multiple comparisons using the Benjamini--Hochberg False Discovery Rate (FDR) test. Sequences with a *P*-value ≤0.05 were considered as under-represented while those with a 1 −*P*-value ≤0.05 (i.e. a *P-*value ≥0.95) were considered as over-represented for a particular hotspot. The hotspots analyzed were WRC (W = A/T and R = G/A) for AID (Pham et al. [@vey040-B67]); and CCC for APOBEC-3G (A3G) ([@vey040-B97]; Holden et al. [@vey040-B36]; [@vey040-B42]); as well as TC and TTC for the remaining APOBEC3s and APOBEC1 ([@vey040-B7]; [@vey040-B42]; Hultquist et al. [@vey040-B38]; [@vey040-B88]; [@vey040-B78]; [@vey040-B2]).

2.3 Hypermutation analysis
--------------------------

To determine the significance of the mutations and the on-going evolution due to AID and A3 enzymes we used hyperfreq, a method described by [@vey040-B52]. This method uses a Bayesian two-context mutation probability ratio to determine if the number of mutations in a given context (AID/A3 hotspots) is higher than out of context mutations. We ran hyperfreq analyses in four different contexts: GGG, GAA, GA and GYW, the reverse complements of the APOBEC3, APOBEC1, and AID hotspots ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). To evaluate if there is a mutation strand bias in the human gamma-herpesviruses, we then ran hyperfreq on both DNA strands (template and coding strand for the protein coding sequences; top and bottom strands in noncoding sequences). Statistical significance was determined using the one-sided Fisher exact test. The protein coding sequences were collected directly from NCBI and aligned using the TranslatorX server and ClustalW as the alignment tool. TranslatorX translates the nucleotide CDS into amino acids, aligns them, and then back-translates them to DNA nucleotides ([@vey040-B1]). Noncoding sequences were aligned using the command-line version of ClustalW. In each case, the resulting sequences were used as input to hyperfreq. We used reference sequences NC_007605 and NC_009333 for EBV and KSHV, respectively, for the comparison in hyperfreq (see [Supplementary Fig. S6](#sup1){ref-type="supplementary-material"} for an example of a hyperfreq alignment).

3. Results
==========

3.1 Gamma-herpesviruses have evolved to limit WRC and TC motifs
---------------------------------------------------------------

As noted in the Introduction, AID and other A3 genes are up-regulated as part of the Interferon response ([@vey040-B9]), as well as in EBV-transformed B cells. As suggested in a previous study ([@vey040-B14]), continuous evolution with exposure to AID/APOBEC enzymes may drive a reduction in the number of enzyme hotspots in the viral genomes in order to reduce detrimental mutations, particularly in coding regions. This previous study introduced a method to quantify whether there was a statistical reduction (under-representation) of AID/A3 family motifs in viral genomes. Using an updated version of this method, we analyzed a given coding sequence by comparing the number of hotspots (e.g. CCC hotspots for A3G) with a null distribution based on sequences that preserve the amino acid content but shuffle the codons used. If the original sequence falls on the left tail of this distribution, it indicates hotspot under-representation, whereas sequences on the right tail indicate potential over-representation. Because previous results suggested that GC content was a major factor in determining the hotspot under-representation, we used a shuffling method that exchanges nucleotides within a sequence at the third codon position only and therefore does not change GC content (see Section 2). The method is available as a separate software package (CDUR) ([@vey040-B81]).

We used CDUR to quantify AID and A3 hotspot under-representation for the EBV and KSHV reference genomes (NC_007605 and NC_009333). We also hypothesized that any effects on viral evolution might act at different stages of the viral life cycle, and therefore considered distinct lytic life cycle stages, as well as latency separately ([@vey040-B50]). [Figure 1](#vey040-F1){ref-type="fig"} shows the fraction of EBV and KSHV coding sequences in each category with under- or over-representation of TC and TTC hotspots. We found a strong signal for under-representation for TC motifs in both EBV and KSHV. To verify that TC hotspot under-representation was specific to the TC motif, we compared the TC under-representation profile with the other three NC alternative (AC, GC, or CC) profiles and indeed found that under-representation was far greater for TC than for these other motifs ([Supplementary Fig. S2](#sup1){ref-type="supplementary-material"}). There was no observable trend within the lytic cycle stage for either EBV or KSHV, and both viruses had high under-representation for latency-associated genes, in particular KSHV where five of its six latency genes (83%) were under-represented for TC hotspots. Both EBV and KSHV infect and undergo their lytic cycle in epithelial cells, where A3B and A3H, which both recognize TC motifs, are expressed at high levels (A3A is most likely not implicated due to having low expression levels). The lytic cycle involves high rates of transcription, at least of lytic genes, and replication both of which may increase the probability of exposing ssDNA to A3 enzymes. The pattern of under-representation for TTC motifs ([Fig. 1B](#vey040-F1){ref-type="fig"}) was very similar to that of TC motifs in EBV ([Fig. 1A](#vey040-F1){ref-type="fig"}). This may result, at least in part, as side effect of strong under-representation for the TC motif, since the TC motif is embedded within TTC, leading to a positive correlation between the two motifs ([Table 1](#vey040-T1){ref-type="table"}). However, the correlation is modest and the similarity between TC and TTC is not evident for KSHV, which suggests some direct effect of under-representation for TTC motifs in the case of EBV. Table 1.TC motifs are negative correlated with WRC and CCC motifs. Mean and standard deviation for the correlation of hotspots representation in EBV and KSHV genes.HotspotCCCWRCTC**EBV genes**TTC0.037 ± 0.040−0.102 ± 0.0640.179 ± 0.119CCC−0.065 ± 0.065−0.181 ± 0.056WRC−0.383 ± 0.056**KSHV genes**TTC−0.000 ± 0.039−0.124 ± 0.0490.267 ± 0.061CCC−0.068 ± 0.054−0.200 ± 0.051WRC−0.395 ± 0.048

![TC and TTC hotspot representation and vulnerability in human gamma-herpesvirus genes separated according to their transcription profile kinetics. Upper panel: hotspot representation; lower panel: mutation vulnerability. Under-represented or resistant genes are those with a *P*-value \<0.05; while those with a 1−*P*-value ≤0.05 (i.e. a *P*-value ≥0.95) were considered as overrepresented or vulnerable. *P*-values obtained were adjusted using the Benjamini--Hochberg method. Resistant genes are those in which the action of the cytidine deaminases will have a higher incidence of synonymous changes, susceptible genes those with a higher incidence of nonsynonymous changes, and neutral genes are those with an expected number of nonsynonymous mutations. Genes with under-representation and vulnerable genes are not necessarily the same (see [Supplementary Fig. S4](#sup1){ref-type="supplementary-material"} for genes that overlap). EBV and KSHV transcription profiles as determined by [@vey040-B54] and reviewed in [@vey040-B23], respectively.](vey040f1){#vey040-F1}

In addition to hotspot frequency, another factor to consider is the potential impact of hotspot mutations, in particular whether the mutations cause an amino acid change (nonsynonymous) or not (synonymous mutation) ([@vey040-B14]). The CDUR package evaluates the ratio of non-synonymous mutations to the number of observed hotspots, again comparing the observed ratio with that of the null distribution using the n3 codon shuffling model for each coding sequence (the statistic is labeled as 'repTrFrac', short for 'replacement transition fraction' in CDUR; see Section 2). Here, for a given gene, if the observed ratio falls on the left tail of the distribution, that is, fewer than expected nonsynonymous mutations, then we describe the gene as being mutationally 'resistant', whereas if it is on the right tail, we describe the gene as mutationally 'vulnerable' ([@vey040-B14]). We hypothesized that if a viral genome was under A3 mutational pressure during its evolution, not only would the number of hotspots be reduced, but also the remaining hotspots would predominantly cause nonsynonymous replacements if mutated, making the gene mutationally 'vulnerable'. In other words, by reducing the number of hotspots that cause synonymous mutations, the proportion of hotspots which may deleteriously alter the protein would increase. For example, it has been shown in HIV-1 sequences that patients with a nucleotide sequence of TGGG, that is, a tryptophan codon (TGG) followed by a G, is susceptible to A3G editing. In such a case, the resulting mutation (G \> A in the underlined G) leads to a premature stop codon (TAG), rendering the resulting protein nonfunctional ([@vey040-B18]). Furthermore, it was shown in this study that patients having this mutation had a better clinical outcome. In agreement with our hypothesis, we found that both EBV and KSHV are strongly enriched in significantly 'vulnerable' genes for the TC hotspot ([Fig. 1E and G](#vey040-F1){ref-type="fig"}). Again, the profile for the TTC hotspot is similar to TC, but attenuated ([Supplementary Fig. S4](#sup1){ref-type="supplementary-material"} shows the number of vulnerable genes that also have an under-representation of TC or TTC hotpots).

Although both EBV and KSHV are latent in B cells and these are the primary human cell type to express AID at high levels (albeit only at the germinal center stage), we observed only limited under-representation of AID WRC hotspots in latency genes in KSHV and none at all in EBV ([Supplementary Fig. S3A and C](#sup1){ref-type="supplementary-material"}). Interestingly, there is a relatively strong negative correlation between WRC and TC motifs ([Table 1](#vey040-T1){ref-type="table"}), which is a consequence of the contexts at the −1 position (R = A/G vs T) being mutually exclusive. Thus, there is a tradeoff between APOBEC3 TC hotspots and AID WRC hotspots in which APOBEC3 may dominate if, for example, APOBEC3 acted strongly on all genes, including latency genes, during lytic replication.

Specifically, in EBV, there is an over-representation of CCC motifs (A3G), particularly for late lytic genes (H9, [Supplementary Fig. S3B](#sup1){ref-type="supplementary-material"}). Hotspot over-representation is less straightforward to interpret in terms of its mechanistic and evolutionary consequences. It may arise to promote diversity, as has been proposed in the context of HIV ([@vey040-B74]), or it may also arise as a consequence of correlations with other motifs. CCC motifs are negatively correlated with TC motifs, and to an extent with WRC (AID) ([Table 1](#vey040-T1){ref-type="table"}). Even while there is an increase in A3G mRNA levels in EBV-transformed lymphocytes ([Supplementary Fig. S1B](#sup1){ref-type="supplementary-material"}) and a higher probability of being mutated by enzyme due to the over-representation, mutations due to A3G may not be as detrimental for the virus given that A3G has been shown to be predominantly cytoplasmic which suggests that the virus, which replicates in the nucleus, may not be as exposed to A3G as it would be to AID or other APOBEC3s. Furthermore, since the virus may need a certain GC content for its functions, it would be advantageous in this case to place a large portion of its G/C nucleotides in CCC motifs which would less likely be mutated, though this has not been shown. EBV and KSHV have a CDS mean GC content of 59 and 53% in coding regions, which may suggest a functional need for a higher GC content. One example for EBV is the nucleotide sequence in the Gly--Ala repeat region of the EBNA-1 protein, which has a strong codon bias (using GCA for Ala and GGR for Gly). Furthermore, this repeat region is critical to inhibit antigen presentation through the major histocompatibility complex (MHC) class 1 pathway ([@vey040-B46]; Apcher et al. [@vey040-B3]). In our analysis, we found that mutations caused by A3G would result in non-synonymous amino acid changes in this region of EBV EBNA-1 latency-associated protein that would not be tolerated physiologically. In other sequences, there may be a need for specific mRNA secondary structures that may drive a particular GC content, as it has been shown for RNA viruses ([@vey040-B83]). Almost all KSHV genes have a neutral representation of A3G hotspots, consistent with the fact that the type of cells KSHV infects is much broader than EBV.

Genes that have a depletion of TC motifs include those involved in virus DNA replication, host immune system regulation, control of lytic gene expression, and virion function and structure ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}). The genes overlap to a large extent with those depleted of TTC motifs. Notably, the latency-associated proteins EBNA-2 and -3A showed a depletion of TC and TTC hotpots; however, of the LMP genes, only LMP-2B showed depletion for TC hotspots. To determine if the different LMP1 variants described in EBV associated malignancies differ in AID/A3 hotspot representation, we analyzed the six different LMP1 variants described by [@vey040-B25] for hotspot representation. No difference in TC, TTC, or WRC hotspot representation was observed when compared with the reference strain NC_007605; however, four variants (NC, Alaskan, China 1, and China 2) have a depletion of CCC hotspot.

Two key immediate-early genes of EBV, BZLF1, and BRLF1 (that code for the transcriptional activators Zta and Rta, respectively) were also significantly depleted for TC hotspots. These transcriptional activators are sufficient to induce lytic replication in EBV latently infected B cells or epithelial cells. In KSHV, along with genes with significant depletion of TC motifs also overlap with EBV in terms of function; in particular, the majority of KSHV latency-associated proteins, including LANA-1 ([Supplementary Table S4](#sup1){ref-type="supplementary-material"}). While this article was under review, a new study was published showing that the EBV lytic gene BORF2, can bind to and stoichiometrically inhibit the deaminase activity of A3B ([@vey040-B15]). Interestingly, we found that BORF2 was significantly underrepresented for both TC and TTC motifs (*P* \< 10^−3^ and *P* = 0.014, respectively, FDR corrected), which would be consistent with minimizing the potential for APOBEC mutations occurring before the availability of BORF2 protein. ORF 61, the BORF2 ortholog in KSHV, was also found to have underrepresentation for both these motifs (*P* = 0.015 and *P* = 0.029, respectively). Both EBV BORF2 and KSHV ORF 61 were also classified as significantly susceptible with respect to amino acid changes, lending further support to their having evolved under mutational pressure. Overall, our results suggest that the human gamma-herpesviruses have evolved to reduce the presence and impact of TC hotspots and, to a lesser extent, for TTC hotspots. The over-representation of CCC (A3G) hotspots may in part arise from a negative correlation with the relatively strong signal for TC hotspot under-representation.

3.2 WRC and TC motifs in the CDS in EBV are targeted more frequently than TTC or CCC motifs
-------------------------------------------------------------------------------------------

In the analysis above we considered the profile of A3 hotspots, which is informative as to the evolutionary history of these viruses but does not provide evidence for any hypermutation trends, if any exist. A reduction in hotspots for one APOBEC enzyme, A3B, for example, might increase the relative probability for another, such as AID. In a recent *ex vivo* study, [@vey040-B87]) showed A3C hypermutation of the latency associated EBNA-1 and -2 genes in human PBMC lines and *in vivo* from a patient, respectively. However, the impact of A3C and other cytidine deaminases in other EBV coding sequences, as well as in KSHV remains unknown. We employed a Bayesian statistic method (hyperfreq) as described by [@vey040-B52] to look for AID/A3-dependent hypermutation in EBV and KSHV coding sequences (see Section 2). [Table 2](#vey040-T2){ref-type="table"} summarizes the number of genes that showed the evidence of significant AID/A3 hypermutation, according to the hyperfreq package, in at least one of the nine EBV genomes used in this study. We identified a slightly higher number of TC-dependent and WRC (AID)-dependent hypermutated genes than TTC and CCC (A3G), although not statistically significant. Given that CCC-dependent mutation appears to be less common, this again suggests that although the virus is over-represented for CCC motifs, it is not frequently exposed to the enzyme. Table 2.Hypermutated genes. Total count of genes shows genes that were hypermutated in at least one of the EBV or KSHV genomes used in this study.Hypermutated genesNot hypermutated genes**EBV** TC3250 TTC2755 WRC3151 CCC2260**KSHV** TC3349 TTC2656 WRC3547 CCC2161

Next, we analyzed the specific genes that were targeted by AID/A3 enzymes. [Table 3](#vey040-T3){ref-type="table"} lists the EBV genes that showed AID- or A3-dependent hypermutation in 40% or more of the genomes analyzed, their function and transcription profile during the lytic cycle (see [Supplementary Table S5](#sup1){ref-type="supplementary-material"} for the complete list of genes that showed evidence of hypermutation). Genes with AID-dependent (WRC) hypermutation included genes involved in the production of new virions (BFRF1, BFRF1A, BFRF2, BFLFL2, and BDLF4). BFRF2 and BDLF4 (together with four other proteins) form a complex required for the expression of late genes. BFLFL2 and BFRF1 form the nuclear egress complex that is required for the exit of the assembled capsid and BFRF1A is involve in DNA packaging. Targeting of these genes by AID is consistent with their expected expression in B cells. Certain genes (BALF2, BALF4 and BNRF1) showed both TC-dependent hypermutation and TC hotspot under-representation ([Table 2](#vey040-T2){ref-type="table"} and [Supplementary Table S3](#sup1){ref-type="supplementary-material"}) suggesting both past and ongoing mutational targeting. The BALF2 gene, which also showed TTC-dependent hypermutation, codes for a ssDNA-binding protein, and therefore mutations in this gene could affect their DNA binding leading to longer exposure of the ssDNA to mutagenic enzymes such as the AID and A3 enzymes. Given the importance of the BALF2 gene, we compare the number of mutated CDSs in genomes with and without hypermutated BALF2 gene. We did not find a correlation between mutated BALF2 genes and higher number of mutated CDSs; however, the BALF2 gene showed both TC hotspot under-representation and vulnerability to TC hotspot mutations suggesting that exposure to A3 could indeed affect their DNA-binding affinity. The BRRF2 gene, which is important for the production of virions, showed TTC-dependent hypermutation. TTC-dependent hypermutation was also observed in the BALF4 gene, which codes for glycoprotein B, and mutations in this gene could affect residues that may have important roles in virus specific entry. Together these results suggest that the AID/A3 enzymes are targeting some EBV lytic genes that are important for the production of new virions. Table 3.AID- and APOBEC3-dependent hypermutation in EBV genes.GeneTranscription profile[^a^](#tblfn1){ref-type="table-fn"}FunctionMotif (hypermutated genomes)BFRF23 hMediate late gene transcription ([@vey040-B21])WRC (6)BDLF36 hEnhances epithelial infection, virion protein ([@vey040-B29])TC (6)BNRF1UnknownMajor tegument protein ([@vey040-B29])TC (5)LF112 hUncharacterized proteinTC (5)BRRF26 hProduction of infectious progeny ([@vey040-B92])TTC (5)BDLF46 hRequired for expression of late genes ([@vey040-B29])WRC (5)BALF49 hgB-fusion protein, virion protein ([@vey040-B29])TTC (5), WRC (4)LMP1LatentTC (4), TTC (4)BFLF26 hRequired for Nuclear Egress---Binds BFRF1 ([@vey040-B29])TTC (4), WRC (4)BALF23 hSingle stranded DNA-binding protein ([@vey040-B29])WRC (4), CCC (4)EBNA3BLatentCCC (4)BFRF13 hEssential for primary viral envelopment and egress ([@vey040-B28])WRC (4)BFRF1AUnknownDNA packaging ([@vey040-B64])WRC (4)BGLF13 hCapsid maturation/DNA packaging, Virion protein ([@vey040-B29])WRC (4)LF26 hImmune evasion and regulation of lytic activation ([@vey040-B95]; Heilmann, Calderwood, and Johannsen [@vey040-B34])TTC (4)[^1]

The APOBEC enzymes preferentially target ssDNA cytosines on the coding strand of the transcription bubble or those on the lagging strand of the replication fork ([@vey040-B6]; [@vey040-B37]). To determine if the AID/A3 enzymes target the coding sequences during transcription, then we consider the evidence of hypermutation in both template and coding strands ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}). We identified a significant preference of AID-dependent hypermutation for the coding strand (*P*-value 0.01656) in EBV genomes, as would be predicted if AID was acting during transcription. Also, there seems to be a slight preference for hypermutation in the coding strand by A3G, although the difference is not statistically significant. We performed this analysis, but did not find any statistically significant bias for the other APOBECs.

3.3 AID and A3 enzymes target mostly early and late expressed genes in KSHV
---------------------------------------------------------------------------

We next considered KSHV and used the CDS of 18 KSHV genomes available in Genbank to look for the evidence of AID/A3 enzyme hypermutation. [Table 2](#vey040-T2){ref-type="table"} shows the number of genes that were hypermutated in at least one of the 18 KSHV genomes. Similar to EBV, the number of AID- and TC-dependent hypermutated genes was slightly higher than those with TTC and CCC hotspot mutations, however, they were statistically significant only for CCC (TC vs CCC *P*-value 0.01592 and WRC vs CCC *P*-value 0.03354). [Table 4](#vey040-T4){ref-type="table"} shows the hypermutated genes in 40% or more of the genomes, their function and transcription profile (see [Supplementary Table S7](#sup1){ref-type="supplementary-material"} for complete list). Hypermutation was mostly observed in early or late genes ([Table 4](#vey040-T4){ref-type="table"}). Genes with WRC (AID) hypermutation were mostly associated with host immune regulation. ORF75, which also plays a role in immune evasion, was hypermutated at TC and TTC hotspots and also showed under-representation for TC and TTC. Except for AID, the number of hypermutated sequences in the template strand was slightly higher than the coding strand; however, the difference was not statistically significant in any of the cases ([Supplementary Table S8](#sup1){ref-type="supplementary-material"}). Altogether these results suggest that AID/A3 enzymes are predominantly targeting genes involved in host immune evasion. Table 4.AID- and APOBEC3-dependent hypermutation in KSHV genes.GeneTranscription profile[^a^](#tblfn2){ref-type="table-fn"}FunctionMotif (hypermutated genomes)K14EarlyImmune evasion (reviewed in [@vey040-B69])WRC (11)ORF63EarlyImmune evasion (reviewed in [@vey040-B69])WRC (8)ORF22LateGlycoprotein H ([@vey040-B29])WRC (13)ORF54EarlyImmune evasion ([@vey040-B51])WRC (8)ORF49EarlyTranscription factor ([@vey040-B29])TTC (8)ORF75[^b^](#tblfn3){ref-type="table-fn"}LateImmune evasion ([@vey040-B69])TTC (10), TC (9)ORF68LateVirion glycoprotein ([@vey040-B29])CCC (8)[^2][^3]

3.4 AID targets the oriP origin of replication sequence in EBV
--------------------------------------------------------------

During latency, the origin of replication (oriP) site is responsible for the initiation of replication and maintenance of the episome. EBV contains a single oriP site, which consists of two functional domains that contain EBNA-1-binding sites: the dyad symmetry sequence and the family of repeats (FR). The interaction between the major latency protein (EBNA-1) and the oriP sequence is essential for the stability and replication of the viral episome (reviewed in [@vey040-B32]). Given its importance, we sought to evaluate AID/A3 hotspot under-representation and evidence of hypermutation for this particular noncoding subregion. Because oriP is a noncoding sequence we used a random shuffle to evaluate the under-representation (see Section 2). Largely consistent with the trends we observed in coding regions, we found that the oriP sequence has an under-representation for TC and TTC motifs, a neutral representation of WRC motifs and over-representation of CCC motifs ([Supplementary Table S9](#sup1){ref-type="supplementary-material"}).

We next evaluated if there was evidence of hypermutation in the EBV oriP sequence. The number of EBNA-1-binding sites, as defined by the motif GRWWRYVYRYVCTDYY ([@vey040-B24]), in the genomes analyzed varies from 19 to 28, most of which belong to the FR repeats region. To avoid possible false positive results arising from hotspots within the FR repeats, we removed the FR repeats from the sequences before generating the sequence alignment. We found the evidence of TC-dependent hypermutation on both strands of the oriP sequences in four of the EBV genomes. We also identified two genomes with WRC- and TTC-dependent hypermutation in the top and bottom strands, respectively ([Supplementary Table S10](#sup1){ref-type="supplementary-material"}), but no evidence of CCC hypermutation. [Figure 2](#vey040-F2){ref-type="fig"} shows the mutation frequency (frequency of minor alleles) that arises from the alignment. The bottom part of the figure also shows the positions of the AID/A3 hotspots based on the alignment consensus sequence. As shown in the figure, there is a high density of AID hotspots (WRC and its reverse complement motif GYW) throughout the entire EBV oriP sequence. However, the FR (nucleotides 138--715) has a far higher mutation frequency than the rest of the sequence. Interestingly, given the EBNA-1-binding site consensus sequence (GRWWRYVYRYVCTDYY), AID-dependent mutations at WRC hotspots within the FR region appear to strongly avoid affecting the integrity of the EBNA-1-binding sites. Within this relatively short sequence there are twenty-six possible WRC hotspots in the EBNA-1-binding site consensus sequence (taking into account the ambiguous nucleotides and considering both strands) and of these, twenty-five can tolerate a C--T mutation. Unfortunately, for KSHV there is only one oriP sequence in Genbank so we were unable to assess AID/A3 hypermutation.

![Mutation frequency and distribution of the AID and APOBEC3 activity in the EBV oriP sequence. The *x*-axis shows the hotspots sites within the gene. The *y*-axis represents the mutation frequency for each site. Each colored dot in the bottom panels represents an AID or A3 hotspot (or their reverse complement sequence) as labeled at both edges.](vey040f2){#vey040-F2}

During the lytic cycle, EBV replication starts from the oriLyt. EBV usually have two oriLyt copies that contain Zta response elements to which the transcriptional activator Zta bind and recruit other viral replication proteins ([@vey040-B79]; El-Guindy, Heston, and Miller [@vey040-B26]). Given the importance of this region for the viral replication and spreading, we evaluate the AID/A3 hotspot representation and hypermutation. Similar to the trends observed in the rest of the viral genome we found an under-representation of TC and WRC hotspots, neutral representation of TTC hotspots, and an under-representation of CCC hotspots ([Supplementary Table S11](#sup1){ref-type="supplementary-material"} and [Fig. S5](#vey040-F1){ref-type="fig"}). Once again, the over-representation of CCC hotspots could be as a result of the avoidance of other A3 and AID enzymes and the fact that the virus is not exposed as often to A3G enzymes. We did not find evidence of hypermutation due to AID/A3 enzymes in the oriLyt sequenced for any of the analyzed genomes. These results, once again, suggest that EBV has evolved to limit the detrimental effects of both AID and TC-targeting A3 enzymes.

4. Discussion
=============

We have analyzed human gamma-herpesvirus genomes to investigate the evolutionary consequences of exposure to AID/A3 family enzymes. Our results suggest that human gamma-herpesviruses, in general, are under evolutionary pressure, and are subject to AID/A3 hypermutation. Moreover, human gamma-herpesviruses have evolved to limit the action of AID/A3 enzymes. In a previous study, we found that hotspot under-representation measures could be affected by several factors apart from direct hotspot avoidance, including codon bias and especially GC content ([@vey040-B14]). For this study, we therefore adopted a new method (CDUR; [@vey040-B81]) in which the shuffling method used to generate the null model strictly maintains the GC content while introducing minimal changes to the codon usage bias.

In response to an infection, host cells may coexpress several AID/A3 enzymes (together with activation of many other immune pathways, of course). As a consequence of differences in the hotspots of the AID/A3 enzymes, many of which are mutually exclusive, it would be extremely difficult for any virus to evolve under-representation for all hotspots simultaneously. When analyzing genomes for hotspot under-representation we also considered whether those mutations would be synonymous or nonsynonymous, under the hypothesis that AID/A3 evolutionary pressure would both reduce hotspot number and increase the impact of the remaining 'indispensable' hotspots. This dual signal was observed most strongly for TC motifs. Many EBV and KSHV genes are thus vulnerable to A3-mediated amino acid changes at TC motifs, including the latency associated EBNA-3A and -3B in EBV and the majority of KSHV latency proteins. Specifically, for the latency proteins, the amino acid changes may lead not only to protein dysfunction, but also to cancer. For example, because LMP-1 activity is critical for latency maintenance and induces NF-kB activity, it has been suggested that its disruption or single amino acid variations may drive tumors ([@vey040-B5]; [@vey040-B71]).

Under-representation for one AID/A3 motif may lead to under- (or over-)representation of another motif as a consequence of correlations, both positive and negative, between different motifs. Unsurprisingly, the TC motif is positively correlated with the motif TTC, which contains a TC. Both TC and TTC are negatively correlated with the nonoverlapping motif CCC. Thus, the over-representation we observe for the CCC motif (A3G) in both EBV and KSHV may well be a consequence of TC under-representation rather than direct selection. Our results suggest that A3B may be the primary deaminating A3 enzyme due to the predominant nuclear localization of A3B ([@vey040-B76]) compared with the other APOBEC3s, as well as high relative expression (A3B is expressed \>6-fold higher in EBV-transformed lymphocytes versus spleen cells---[Supplementary Fig. S1B](#sup1){ref-type="supplementary-material"}). However, we cannot rule out the fact that other APOBECs are responsible which have also been shown to have nuclear localization ([@vey040-B57]; [@vey040-B43]; [@vey040-B76]) may be responsible. Even though A3B and A3H enzymes recognize the same hotspot (TC) as do A3C and A3F enzymes (TTC), it would appear to be more likely that A3B and A3C enzymes are the ones targeting the gamma-herpesviruses genomes for biological reasons. However, as stated previously, we cannot completely rely on hotspot motifs to conclusively differentiate between APOBEC3s, save for A3G. A3B is predominantly nuclear, while A3H shuttles between the nucleus and the cytoplasm; also, A3H tends to oligomerize in the cell ([@vey040-B44]; Gu et al. [@vey040-B31]; [@vey040-B39]). A3C can be found in the nucleus and cytoplasm while A3F has been shown to be strictly cytoplasmic ([@vey040-B44]). Many studies have shown that A3B is constitutively nuclear ([@vey040-B8]; [@vey040-B85]; Stenglein, Matsuo, and Harris [@vey040-B86]; [@vey040-B63]; [@vey040-B43], [@vey040-B44]; [@vey040-B77]), and this nuclear import is determined by distinct sets of residues in the N-terminal domain of the enzyme ([@vey040-B75]). A3H has been shown to be primarily cytoplasmic, and that RNA binding is required for this cytoplasmic localization ([@vey040-B80]). However, this was shown by using RNA-binding mutants in the tumor cell lines 293T and HeLa cells. Other studies have also shown that A3H is primarily cytoplasmic ([@vey040-B38]; [@vey040-B48]), but these and other ([@vey040-B84]) studies also showed the existence of A3H haplotypes that have nuclear localization. A3C has been shown to shuttle between the nucleus and cytoplasm, while A3F has been shown to be predominantly cytoplasmic during both interphase and mitosis ([@vey040-B44]). The results of these studies, together with the median expression levels reported ([Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}), suggest it may be more likely that A3B and A3C are the enzymes responsible for deaminating gamma-herpesviruses, as those have both been shown to have greater nuclear localization than A3H and A3F, respectively. However, we cannot rule out the possibility of A3H and A3F enzymatic activities as the sources for the reported mutations. At the same time, most of the studies cited above used overexpression of the respective APOBEC3 enzyme, some in nonrelevant cell types, to show nuclear or cytoplasmic localization. As such, further exploration is required to confirm that A3B and A3C are indeed the enzymes responsible for targeting gamma-herpesviruses.

The CCC motif over-representation could also be a decoy mechanism that the EBV has evolved to sequester the AID enzyme. Biochemical studies have established that AID avoids 'SYC' motifs (S = G or C and Y = T or C) ([@vey040-B65]; Chelico, Pham, and Goodman [@vey040-B13]). The CCC motif is embedded within these 'coldspots', and these instances of over-representation of CCC, which is accompanied with high resistance, could be used as a decoy mechanism to sequester the AID enzyme and limit the low frequency of mutations to specific regions of the viral genome. Something similar might be happening with the high fraction of genes that showed an over-representation of CCC motifs.

Even though both EBV and KSHV increase the level of AID expression in infected B cells we did not observe an under-representation of AID hotspots. Both viruses may have evolved various mechanisms to reduce AID action directly. When expressed, the EBV latency protein EBNA-2 can inhibit AID expression ([@vey040-B89]); EBV also causes increased expression of endogenous miR-155 and miR-93 ([@vey040-B98]; Namba-Fukuyo et al. [@vey040-B60]), which prevent AID translation ([@vey040-B22]; [@vey040-B49]; Borchert, Holton, and Larson [@vey040-B10]). KSHV uses LANA-1 to recruit UNG2 (Uracil DNA glycosylase 2) which may neutralize the mutagenic effects of AID; also, the virus uses two miRNAs (K12-11 and K12-5) to again repress AID translation ([@vey040-B90]).

Even though both EBV and KSHV have mechanisms to reduce AID-dependent mutations as we have discussed, our results suggest that AID, together with certain A3 enzymes, are in fact editing the viral genomes. Since the substrate for these enzymes is ssDNA, it has been suggested that there will be more lagging or coding strand mutations than in the leading or template strand during replication and transcription, respectively ([@vey040-B87]; Hoopes et al. [@vey040-B37]). However, we found that AID and A3 enzymes target both strands in human gamma-herpesviruses in accordance with previous observations by [@vey040-B87]. This result could be explained by the fact that EBV episome replication can start from multiple sites, not only from the oriP, as demonstrated by [@vey040-B61]. Moreover, in this last study, the authors not only observed changes in the duplication speed and replication fork movement in the DNA segments replicated, but also that the frequency of initial replication from the oriP varies among strains. In light of these previous results, it is not possible to confirm which CDSs are within the lagging or the leading strand during episome replication. Another fact that may explain why we observed hypermutation in the template and coding strands could involve the unidirectional replication of EBV when the replication starts from the oriP. It is known that EBNA-1 causes a stalling of the replication fork in the FR region within the oriP sequence ([@vey040-B19]), and when this happens the replication fork can move such a way that the top is always the lagging strand and the bottom strand is leading. As a result, some of the sequences that serve as the template strand during transcription will be in the lagging strand during replication, and vice versa. If the mutations arise when the episome is replicating only from the oriP the AID/A3 enzymes may be competing with the virus ssDNA-binding proteins as suggested by [@vey040-B93]. The same explanation may apply to KSHV since we saw mutations in both strands and it was recently shown that LANA-1 protein also causes a stalling of the replication fork at the terminal repeat regions ([@vey040-B20]). During canonical somatic hypermutation in B cells, AID activity is associated with transcription rather than replication of the DNA ([@vey040-B45]); however, in a recent study, it was shown that AID mutagenic activity is restricted to the early G1 phase of the cell cycle ([@vey040-B91]). The fact that EBV lytic reactivation, which can occur in B cells ([@vey040-B72]), induces a G0/G1 cell cycle arrest ([@vey040-B30]) could explain the observed AID-dependent hypermutation in the oriP region, as this region will be found as ssDNA only during viral DNA replication. The fact that we did not found evidence for AID-dependent hypermutation in the two oriLyts sequences is consistent with the under-representation of the WRC hotspots.

In our analysis, we found that mutations caused by A3G will result in nonsynonymous amino acid changes in the Gly--Ala repeat of the EBV EBNA-1 latency-associated protein. This region of the protein has a high codon usage bias (GCA for Ala and GGR for Gly), and studies have shown that this repeat region is critical to inhibit antigen presentation through the MHC class 1 pathway ([@vey040-B47]; Apcher et al. [@vey040-B3]). It seems that amino acid changes are not tolerated in this region ([@vey040-B3]), and therefore A3G activity (with its processive and cooperative action; [@vey040-B12]; [@vey040-B11]) in this region could have a strongly detrimental effect for the virus, although given the predominantly cytoplasmic localization of A3G ([@vey040-B44]), this may occur with low probability.

In conclusion, our results suggest that, even though many EBV and KSHV genes have evolved to limit the action of the AID/A3 enzymes, especially in WRC (AID) and TC motifs, these viral genomes are indeed subjected to AID- and A3-dependent hypermutation. The high under-representation of TC motifs and the presence of TC-dependent mutations is consistent with the fact that this enzyme has a nuclear localization, making it more likely that viral DNA is exposed. However, as stated previously, we cannot ignore that other A3 enzymes other than A3B can be responsible for deamination at TC motifs ([@vey040-B76]; [@vey040-B77]). The existence of specific viral mechanisms to reduce AID activity may have evolved in response to high AID expression in germinal center B cells, and may also explain why we observe only neutral (rather than under-)representation of AID motifs. The number of A3-dependent mutations observed raises the possibility of counteraction mechanisms for these proteins. It will be particularly interesting to determine if the viruses have counter-defense mechanisms against TC-targeting A3s since our analysis showed that many mutations at TC hotspots would be nonsynonymous. Our analysis of hypermutation may well be underestimating the number of mutations since the method we employed to determine the hypermutation relies on a relatively limited number of genomes against a reference sequence. The protein variants that could result from AID/A3 activity may be important, not only for viral fitness, but also for vaccines (epitope determination) and cancer development.
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[^1]: Hours after lytic induction as determined by [@vey040-B54].

[^2]: Transcription profile as reviewed in [@vey040-B23]. Early, \<24 h postinfection; late, \>24 h postinfection.

[^3]: Seventeen genomes.
